Urolithiasis Management Devices Market Size & Growth Forecast 2027–2036, By Segments (Treatment Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Urolithiasis Management Devices Market size was worth USD 1.82 billion in 2026 and is poised to grow at a 4.56% CAGR between 2027 and 2036, exceeding USD 2.84 billion by 2036. The industry revenue for 2027 is assessed at USD 1.89 billion.
Get more details on this report
Request Free Sample ReportUrolithiasis Management Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to advanced endourology systems, high procedure volumes, and strong adoption of minimally invasive kidney stone treatments across hospitals and specialty centers.
- Asia Pacific grows at 5.76% CAGR driven by expanding urology infrastructure, increasing access to minimally invasive procedures, and rising adoption of modern stone management devices.
Segment Momentum
- Intracorporeal Lithotripsy held a 36.68% market share in 2026, supported by its routine use in endoscopic stone fragmentation and its suitability across a wide range of minimally invasive treatment settings.
- ASCs are gaining momentum because minimally invasive stone procedures fit well with efficient outpatient workflows, helping providers improve patient throughput while managing operating costs effectively.
Market Expansion Drivers
- Increasing global kidney stone prevalence driving demand for minimally invasive treatment devices.
- Rising obesity and sedentary lifestyles contributing to higher incidence of urinary stone disorders.
- Technological advancements in lithotripsy and ureteroscopy improving procedural precision and recovery outcomes.
Leading Market Participants
- Key companies in the urolithiasis management devices market include Boston Scientific Corporation (United States), ConMed Corporation (United States), Cook Medical LLC (United States), Dornier MedTech GmbH (Germany), Karl Storz SE & Co. KG (Germany), Olympus Corporation (Japan), Lumenis Ltd. (Israel), Siemens Healthineers AG (Germany), BD (Becton, Dickinson and Company) (United States), Guangzhou Potent Optotronic Technology Co., Ltd. (China).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.82 billion
- 2027 Estimated Market Size: USD 1.89 billion.
- Projected Market Size: USD 2.84 billion by 2036
- Growth Forecast: 4.56% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Intracorporeal Lithotripsy (Treatment Type) | Hospitals & Clinics (End-use)
- Emerging Opportunity Segment: Intracorporeal Lithotripsy (Treatment Type) | Ambulatory Surgical Centers (ASCs) (End-use)
Market Growth Drivers and Industry Trends
Increasing global kidney stone prevalence driving demand for minimally invasive treatment devices
The increasing prevalence of kidney stones is creating sustained procedural demand in the urolithiasis management devices market as more patients require interventions to remove or fragment urinary stones. Minimally invasive approaches offer alternatives to more extensive surgical procedures by enabling clinicians to access and treat stones through smaller entry points or natural urinary pathways. Growing clinical preference for techniques that reduce tissue trauma, shorten recovery periods, and improve patient comfort is encouraging healthcare facilities to expand their use of specialized stone management equipment. This trend is increasing utilization of devices designed for stone visualization, fragmentation, retrieval, and controlled removal during urological procedures.
Rising obesity and sedentary lifestyles contributing to higher incidence of urinary stone disorders
Changes in lifestyle patterns are contributing to metabolic and dietary conditions associated with urinary stone formation, thereby supporting demand within the urolithiasis management devices market. Obesity and sedentary behavior can be accompanied by dietary patterns, metabolic changes, and reduced physical activity that may increase the risk of developing urinary calculi in susceptible individuals. As these risk factors become more prevalent, healthcare providers are encountering a broader patient population requiring diagnostic evaluation and, in some cases, procedural intervention. The resulting need to manage recurring or symptomatic stones is supporting the use of endoscopic and other minimally invasive devices in urological care.
Technological advancements in lithotripsy and ureteroscopy improving procedural precision and recovery outcomes
Advances in lithotripsy and ureteroscopy are enhancing the effectiveness and precision of stone treatment, strengthening the urolithiasis management devices market growth. Modern systems provide clinicians with improved visualization, controlled energy delivery, and greater maneuverability when locating and treating stones within the urinary tract. Refinements in ureteroscopes, lithotripsy technologies, and stone retrieval instruments can facilitate more targeted procedures while limiting unnecessary tissue disruption. These improvements support clinical efforts to achieve effective stone clearance with reduced procedural burden and enable patients to recover more efficiently following treatment.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing global kidney stone prevalence driving demand for minimally invasive treatment devices | 2.00% | Moderate | North America, Europe | High | Near Term |
| Rising obesity and sedentary lifestyles contributing to higher incidence of urinary stone disorders | 1.50% | Low | Asia Pacific, North America | High | Mid Term |
| Technological advancements in lithotripsy and ureteroscopy improving procedural precision and recovery outcomes | 1.30% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The urolithiasis management devices market was led by North America in 2026, reflecting strong adoption of advanced minimally invasive technologies, well-developed urological care infrastructure, and high availability of specialized treatment facilities. Established clinical expertise and increasing preference for procedures that reduce recovery time are encouraging the use of sophisticated stone-management devices. Continued investment in hospital equipment and greater emphasis on efficient diagnosis and treatment of urinary stones further reinforce the region’s market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to register the fastest growth, supported by rising incidence of urinary stone disorders, expanding hospital infrastructure, and improving access to specialized urological care. Growing healthcare expenditure and the gradual adoption of minimally invasive treatment approaches are encouraging facilities to upgrade their procedural capabilities. Increasing patient awareness and broader availability of advanced urology services are also creating favorable conditions for market expansion across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Endourology FocusGermany prioritizes technologically advanced urolithiasis management devices that support accurate diagnosis and minimally invasive intervention. Hospitals continue integrating high-performance lithotripsy and endoscopic solutions to improve procedural consistency and clinical efficiency.
France 🇫🇷
Integrated Urology PracticeFrance supports urolithiasis management through coordinated hospital-based urology services emphasizing effective stone removal and patient-centered treatment. French providers continue adopting versatile devices that enhance procedural flexibility while maintaining high standards of clinical care.
Italy 🇮🇹
Endoscopic Treatment ExpansionItaly continues strengthening endoscopic approaches for urinary stone management through broader adoption of specialized urology devices. Italy places importance on equipment that improves treatment efficiency, procedural accessibility, and consistent outcomes across healthcare facilities.
Japan 🇯🇵
Minimally Invasive EfficiencyJapan advances urolithiasis management through widespread use of compact, minimally invasive treatment technologies suited to specialized urology practice. Japan continues emphasizing procedural safety, equipment precision, and efficient management of recurrent urinary stone cases.
South Korea 🇰🇷
Technology-Driven UrologySouth Korea increasingly adopts advanced urolithiasis management devices as healthcare providers expand minimally invasive urological services. The country values innovative imaging integration, laser treatment capability, and streamlined clinical workflows across modern hospital settings.
United States 🇺🇸
Advanced Stone TreatmentThe U.S. urolithiasis management devices market emphasizes minimally invasive stone treatment supported by advanced endourology technologies. Healthcare providers increasingly invest in flexible visualization systems, laser platforms, and workflow-efficient equipment that improve procedural precision and patient recovery.
Segment Leadership and Growth Trends
Urolithiasis Management Devices Market Share (%), by Treatment Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportTreatment Type Segment Analysis: Intracorporeal Lithotripsy (Largest & Fastest-Growing Segment)
The intracorporeal lithotripsy segment led the urolithiasis management devices market and represented the largest share of 36.68% in 2026, while also emerging as the fastest-growing segment. Its strong position is supported by the effectiveness of minimally invasive stone-fragmentation techniques, which enable targeted treatment while reducing the need for more invasive surgical procedures. Intracorporeal lithotripsy provides clinicians with greater control during stone removal and can be adapted to different stone locations and clinical conditions, supporting its widespread use in urological care. Continued improvements in lithotripsy technologies, growing preference for minimally invasive interventions, and increasing demand for efficient stone-management procedures are further strengthening adoption of this treatment approach.
End-use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Ambulatory Surgical Centers (ASCs) (Fastest-Growing Segment)
Hospitals & clinics accounted for the largest share of the urolithiasis management devices market in 2026, supported by their comprehensive diagnostic and treatment capabilities. These facilities provide access to specialized urologists, advanced imaging, surgical infrastructure, and post-procedure monitoring, making them important centers for managing complex urinary stone cases. Their ability to accommodate a broad range of procedures and patients with varying clinical needs continues to reinforce their leading position.
Ambulatory surgical centers (ASCs) are expected to represent the fastest-growing segment, driven by increasing preference for minimally invasive procedures in convenient outpatient settings. ASCs can provide focused surgical care with streamlined workflows, shorter facility stays, and potentially lower procedural burdens for suitable patients. The growing shift toward outpatient urological interventions and demand for efficient healthcare delivery are supporting greater adoption of urolithiasis management procedures through these specialized facilities.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Treatment Type | Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others | Intracorporeal Lithotripsy | Intracorporeal Lithotripsy |
| End-use | Hospitals & Clinics, Ambulatory Surgical Centers (ASCs) | Hospitals & Clinics | Ambulatory Surgical Centers (ASCs) |
Competitive Landscape and Market Positioning
Key companies in the urolithiasis management devices market:
1. Boston Scientific Corporation (United States)
2. ConMed Corporation (United States)
3. Cook Medical LLC (United States)
4. Dornier MedTech GmbH (Germany)
5. Karl Storz SE & Co. KG (Germany)
6. Olympus Corporation (Japan)
7. Lumenis Ltd. (Israel)
8. Siemens Healthineers AG (Germany)
9. BD (Becton Dickinson and Company) (United States)
10. Guangzhou Potent Optotronic Technology Co. Ltd. (China)
Technological innovation is playing a critical role in the urolithiasis management devices market as healthcare providers seek minimally invasive treatment solutions. Advanced laser lithotripsy systems, flexible ureteroscopes, and enhanced visualization technologies are improving procedural precision and patient recovery outcomes. Continuous R&D efforts aimed at optimizing stone removal efficiency are also driving product development across the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation (United States) | |||||||
| ConMed Corporation (United States) | |||||||
| Cook Medical LLC (United States) | |||||||
| Dornier MedTech GmbH (Germany) | |||||||
| Karl Storz SE & Co. KG (Germany) | |||||||
| Olympus Corporation (Japan) | |||||||
| Lumenis Ltd. (Israel) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| BD (Becton Dickinson and Company) (United States) | |||||||
| Guangzhou Potent Optotronic Technology Co. Ltd. (China). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Calyxo | Jul-22 | Calyxo successfully closed a USD 32.7 million Series C funding round to support its non-invasive urolithiasis management technology. The capital is directed toward the continued development and commercialization of the CVAC Aspiration system, which utilizes irrigation and aspiration technology to facilitate kidney stone removal without traditional surgery. |
| Applaud Medical | Jan-22 | The U.S. FDA granted breakthrough device designation to Applaud Medical's Acoustic Enhancer technology. Designed for use alongside ureteroscopy with laser lithotripsy, the technology targets the fragmentation of calcium-based urinary stones between 6mm and 20mm, marking a significant advancement in non-invasive stone management capabilities. |
| Boston Scientific | Mar-21 | Boston Scientific entered a definitive agreement to acquire the global surgical business of Lumenis for USD 1.07 billion in cash. This strategic acquisition significantly strengthens the company's kidney stone management portfolio and expands its commercial footprint in the global surgical device market. |
| Olympus Corporation | Jun-20 | Olympus Corporation launched the Soltive Laser System, a thulium fiber laser platform engineered for stone lithotripsy and soft tissue applications. This innovation represents a material technological advancement in energy-based surgical interventions for urolithiasis, enhancing the company’s competitive positioning in the stone management equipment sector. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Urolithiasis Management Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Stone Composition | Calcium-Based Stones, Uric Acid Stones, Struvite Stones, Cystine Stones |
| Stone Burden | Small Stones, Medium Stones, Large Stones, Complex or Multiple Stones |
| Purchasing Model | Direct Hospital Procurement, Group Purchasing Organizations, Medical Device Distributors |
Urolithiasis Management Devices Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Unmet Clinical Needs and Innovation White Space |
|
| Ambulatory Surgery Center Growth Opportunities |
|
| Capital Equipment Replacement Outlook |
|
Need a different cut of the data?
Request Custom ResearchHow big is the urolithiasis management devices market?
What is the expected industry size of urolithiasis management devices by 2036?
How are rising kidney stone cases influencing hospital procurement strategies in the urolithiasis management devices market?
How are lifestyle-driven risk factors shaping long-term demand patterns in urolithiasis management devices?
Which treatment type holds the largest share of the urolithiasis management devices market?
Why are Ambulatory Surgical Centers becoming the fastest-growing end-use segment?
Why does North America dominate the urolithiasis management devices market?
How is Asia Pacific contributing to growth in this market?
Who are the major participants shaping the urolithiasis management devices landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization